Trial Outcomes & Findings for Adaptive Hip Exoskeleton for Stroke Gait Enhancement (NCT NCT05536739)
NCT ID: NCT05536739
Last Updated: 2026-07-01
Results Overview
This outcome represents the error with which the deep learning model embedded into our hip exoskeleton's microprocessor predicts hip joint moments in stroke patients. Specifically, the coefficient of determination (R²) is computed between the predicted hip joint moments and the ground truth measurements. Ground truth measurements are obtained from a laboratory-grade force plate system and inverse dynamics calculations. For these measures, higher R² values (closer to 1.0) indicate better correlation between predicted and actual hip joint moments. This metric provides a comprehensive assessment of the exoskeleton's ability to accurately estimate hip joint moments in stroke patients during tasks, with improved outcomes representing better assistive capabilities for the user.
COMPLETED
NA
12 participants
5 Days
2026-07-01
Participant Flow
Participant milestones
| Measure |
Hip Exoskeleton for Stroke Gait Assistance
This study will be conducted on a sample population of stroke subjects (single arm). Subjects will be tested with the hip exoskeleton and baseline.
|
|---|---|
|
Overall Study
STARTED
|
12
|
|
Overall Study
COMPLETED
|
12
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Adaptive Hip Exoskeleton for Stroke Gait Enhancement
Baseline characteristics by cohort
| Measure |
Hip Exoskeleton for Stroke Gait Assistance
n=12 Participants
This study will be conducted on a sample population of stroke subjects (single arm). Subjects will be tested with the hip exoskeleton and baseline.
|
|---|---|
|
Age, Continuous
|
51.2 Years
STANDARD_DEVIATION 11.8 • n=9 Participants
|
|
Sex: Female, Male
Female
|
3 Participants
n=9 Participants
|
|
Sex: Female, Male
Male
|
9 Participants
n=9 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=9 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=9 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=9 Participants
|
|
Race (NIH/OMB)
Black or African American
|
6 Participants
n=9 Participants
|
|
Race (NIH/OMB)
White
|
5 Participants
n=9 Participants
|
|
Race (NIH/OMB)
More than one race
|
1 Participants
n=9 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=9 Participants
|
|
Region of Enrollment
United States
|
12 Participants
n=9 Participants
|
|
Paretic Side
Right Side
|
5 Participants
n=9 Participants
|
|
Paretic Side
Left Side
|
7 Participants
n=9 Participants
|
|
Stroke Type
Ischemic
|
7 Participants
n=9 Participants
|
|
Stroke Type
Hemorrhagic
|
4 Participants
n=9 Participants
|
|
Stroke Type
Not Reported
|
1 Participants
n=9 Participants
|
|
Time Since Stroke
|
102.75 Months
STANDARD_DEVIATION 64.06 • n=9 Participants
|
|
Height
|
174.5 Centimeters
STANDARD_DEVIATION 6.6 • n=9 Participants
|
|
Weight
|
93.2 Kilograms
STANDARD_DEVIATION 13.1 • n=9 Participants
|
|
Body Mass Index (BMI)
|
30.7 Kilograms / Meters, Squared
STANDARD_DEVIATION 4.5 • n=9 Participants
|
|
Self Selected Walking Speed
|
0.81 Meters per second
STANDARD_DEVIATION 0.25 • n=9 Participants
|
|
Fugl Meyer Assessment - Lower Extremity
|
24.3 Unit on a scale
STANDARD_DEVIATION 5.3 • n=9 Participants
|
|
Mini Balance Evaluations Systems Test (Mini-BESTest)
|
19.3 Units on a scale
STANDARD_DEVIATION 4.1 • n=9 Participants
|
|
Assistive Device
Cane
|
2 Participants
n=9 Participants
|
|
Assistive Device
Ankle Foot Orthosis
|
2 Participants
n=9 Participants
|
|
Assistive Device
Cane and Ankle Mediolateral Support
|
1 Participants
n=9 Participants
|
|
Assistive Device
None
|
6 Participants
n=9 Participants
|
|
Assistive Device
Cane and Ankle Foot Orthosis
|
1 Participants
n=9 Participants
|
PRIMARY outcome
Timeframe: 5 DaysPopulation: This outcome measure was only measured during the hip exoskeleton intervention as it can only be measured if wearing a hip exoskeleton as it is representative of the error with which the deep learning model embedded into the hip exoskeleton microprocessor predicts hip joint moments in stroke patients.
This outcome represents the error with which the deep learning model embedded into our hip exoskeleton's microprocessor predicts hip joint moments in stroke patients. Specifically, the coefficient of determination (R²) is computed between the predicted hip joint moments and the ground truth measurements. Ground truth measurements are obtained from a laboratory-grade force plate system and inverse dynamics calculations. For these measures, higher R² values (closer to 1.0) indicate better correlation between predicted and actual hip joint moments. This metric provides a comprehensive assessment of the exoskeleton's ability to accurately estimate hip joint moments in stroke patients during tasks, with improved outcomes representing better assistive capabilities for the user.
Outcome measures
| Measure |
Hip Exoskeleton for Stroke Gait Assistance
n=12 Participants
This study will be conducted on a sample population of stroke subjects (single arm). Subjects will be tested with the hip exoskeleton and baseline.
|
|---|---|
|
Temporal Convolutional Network (TCN) Model Performance (Joint Moment Accuracy)
|
0.7228 Coefficient of determination
Standard Deviation 0.0846
|
PRIMARY outcome
Timeframe: 5 daysPopulation: 1 participant was excluded due to self-reported physiological condition unrelated to study intervention. 1 participant excluded due to physical difficulty unrelated to study intervention.
Metabolic energy expenditure will be quantified using an indirect calorimetry system (Parvo Medics, UT) that measures oxygen consumption (VO₂) and carbon dioxide production (VCO₂) during experimental tasks. Measurements will be collected from each participant during a 5-minute baseline standing period followed by level ground walking trials under three conditions: without the exoskeleton, with the exoskeleton in a powered state, and with the exoskeleton in an unpowered state. Metabolic cost will be calculated from respiratory gas exchange data using standard equations for energy expenditure.
Outcome measures
| Measure |
Hip Exoskeleton for Stroke Gait Assistance
n=10 Participants
This study will be conducted on a sample population of stroke subjects (single arm). Subjects will be tested with the hip exoskeleton and baseline.
|
|---|---|
|
Metabolic Cost for Level Ground Walking
Baseline
|
1.95 Watts / Kilogram
Standard Deviation 2.45
|
|
Metabolic Cost for Level Ground Walking
Hip Exoskeleton
|
1.85 Watts / Kilogram
Standard Deviation 2.48
|
PRIMARY outcome
Timeframe: 5 daysPopulation: 1 participant was excluded due to self-reported physiological condition unrelated to study intervention. 1 participant excluded due to invalid trial data.
Mechanical work performed by the lower limb joints during level walking will be quantified through biomechanical analysis of motion capture data. Joint moments and angular velocities will be derived through inverse dynamics and kinematics, respectively. Joint power, calculated as the product of joint moment and angular velocity, will be integrated with respect to time using trapezoidal integration to determine mechanical work. Positive work will be calculated by integrating positive joint powers, providing comprehensive quantification of joint energy generation at each joint during level walking.
Outcome measures
| Measure |
Hip Exoskeleton for Stroke Gait Assistance
n=10 Participants
This study will be conducted on a sample population of stroke subjects (single arm). Subjects will be tested with the hip exoskeleton and baseline.
|
|---|---|
|
Biological Joint Work - Level Walking
Baseline
|
0.17 Watts per Kilogram
Standard Deviation 0.055
|
|
Biological Joint Work - Level Walking
Hip Exoskeleton
|
0.154 Watts per Kilogram
Standard Deviation 0.05
|
PRIMARY outcome
Timeframe: 5 daysPopulation: 1 participant was excluded due to self-reported physiological condition unrelated to study intervention. 2 participant excluded due to invalid trial data.
Mechanical work performed by the lower limb joints will be quantified during incline walking through biomechanical analysis of motion capture data. Joint moments and angular velocities will be derived through inverse dynamics and kinematics, respectively. Joint power, calculated as the product of joint moment and angular velocity, will be integrated with respect to time using trapezoidal integration to determine mechanical work. Positive work will be calculated by integrating positive joint powers, providing comprehensive quantification of joint energy generation at each joint during the incline walking.
Outcome measures
| Measure |
Hip Exoskeleton for Stroke Gait Assistance
n=9 Participants
This study will be conducted on a sample population of stroke subjects (single arm). Subjects will be tested with the hip exoskeleton and baseline.
|
|---|---|
|
Biological Joint Work - Incline Walking
Baseline
|
0.273 Watts per Kilogram
Standard Deviation 0.089
|
|
Biological Joint Work - Incline Walking
Hip Exoskeleton
|
0.252 Watts per Kilogram
Standard Deviation 0.071
|
PRIMARY outcome
Timeframe: 5 daysPopulation: One participant excluded due to self-reported physiological symptoms unrelated to the study intervention.
Mechanical work performed by the lower limb joints will be quantified during stair ascent through biomechanical analysis of motion capture data. Joint moments and angular velocities will be derived through inverse dynamics and kinematics, respectively. Joint power, calculated as the product of joint moment and angular velocity, will be integrated with respect to time using trapezoidal integration to determine mechanical work. Positive work will be calculated by integrating positive joint powers, providing comprehensive quantification of joint energy generation at each joint during the stair ascent task.
Outcome measures
| Measure |
Hip Exoskeleton for Stroke Gait Assistance
n=11 Participants
This study will be conducted on a sample population of stroke subjects (single arm). Subjects will be tested with the hip exoskeleton and baseline.
|
|---|---|
|
Biological Joint Work - Stair Ascent
Baseline
|
1.493 Joules per Kilogram per repetition
Standard Deviation 0.375
|
|
Biological Joint Work - Stair Ascent
Hip Exoskeleton
|
1.318 Joules per Kilogram per repetition
Standard Deviation 0.33
|
PRIMARY outcome
Timeframe: 5 daysPopulation: 1 participant was excluded due to self-reported physiological condition unrelated to study intervention. 1 participant did not complete the task due to fatigue from the testing session.
Mechanical work performed by the lower limb joints will be quantified during sit to stand through biomechanical analysis of motion capture data. Joint moments and angular velocities will be derived through inverse dynamics and kinematics, respectively. Joint power, calculated as the product of joint moment and angular velocity, will be integrated with respect to time using trapezoidal integration to determine mechanical work. Positive work will be calculated by integrating positive joint powers, providing comprehensive quantification of joint energy generation at each joint during the sit to stand task.
Outcome measures
| Measure |
Hip Exoskeleton for Stroke Gait Assistance
n=10 Participants
This study will be conducted on a sample population of stroke subjects (single arm). Subjects will be tested with the hip exoskeleton and baseline.
|
|---|---|
|
Biological Joint Work - Sit to Stand
Baseline
|
0.625 Joules per Kilogram per repetition
Standard Deviation 0.128
|
|
Biological Joint Work - Sit to Stand
Hip Exoskeleton
|
0.416 Joules per Kilogram per repetition
Standard Deviation 0.103
|
PRIMARY outcome
Timeframe: 5 daysPopulation: One participant excluded due to self-reported physiological symptoms unrelated to the study intervention. One participant did not complete the task due to fatigue from the testing session.
Mechanical work performed by the lower limb joints will be quantified during a go and grab task through biomechanical analysis of motion capture data. In the go and grab task, participants take several steps, lean forward, and pick up a weighted object from a low surface just above ground level. Joint moments and angular velocities will be derived through inverse dynamics and kinematics, respectively. Joint power, calculated as the product of joint moment and angular velocity, will be integrated with respect to time using trapezoidal integration to determine mechanical work. Positive work will be calculated by integrating positive joint powers, providing comprehensive quantification of joint energy generation at each joint during the go and grab task.
Outcome measures
| Measure |
Hip Exoskeleton for Stroke Gait Assistance
n=10 Participants
This study will be conducted on a sample population of stroke subjects (single arm). Subjects will be tested with the hip exoskeleton and baseline.
|
|---|---|
|
Biological Joint Work - go and Grab
Baseline
|
1.389 Joules per Kilogram per repetition
Standard Deviation 0.248
|
|
Biological Joint Work - go and Grab
Hip Exoskeleton
|
1.077 Joules per Kilogram per repetition
Standard Deviation 0.329
|
SECONDARY outcome
Timeframe: 5 daysPopulation: One participant excluded due to self-reported physiological symptoms unrelated to the study intervention.
This will be measured as the participant walks a distance of 10 meters across a gait mat at their self-selected (or comfortable) walking speed. This measure will be recorded in seconds with lower values indicating faster speed and higher values indicating slower speeds. Self-selected walking speed is highly correlated with functional ability and dependence.
Outcome measures
| Measure |
Hip Exoskeleton for Stroke Gait Assistance
n=11 Participants
This study will be conducted on a sample population of stroke subjects (single arm). Subjects will be tested with the hip exoskeleton and baseline.
|
|---|---|
|
10 Meter Walk Test (Self-selected)
Baseline
|
0.77 Meters per Second
Standard Deviation 0.22
|
|
10 Meter Walk Test (Self-selected)
Hip Exoskeleton
|
0.8 Meters per Second
Standard Deviation 0.17
|
SECONDARY outcome
Timeframe: 5 daysPopulation: One participant excluded due to self-reported physiological symptoms unrelated to the study intervention.
This will be measured as the time it takes a participant to rise from a chair, walk three meters at a self-selected pace, turn, walk back to the chair and sit down. The total time taken will be measured in seconds with longer times indicating poorer physical performance. This test assesses functional mobility and dynamic balance.
Outcome measures
| Measure |
Hip Exoskeleton for Stroke Gait Assistance
n=11 Participants
This study will be conducted on a sample population of stroke subjects (single arm). Subjects will be tested with the hip exoskeleton and baseline.
|
|---|---|
|
The Timed up and go (TUG)
Baseline
|
15.5 Seconds
Standard Deviation 4.36
|
|
The Timed up and go (TUG)
Hip Exoskeleton
|
15.09 Seconds
Standard Deviation 2.55
|
SECONDARY outcome
Timeframe: 5 daysPopulation: One participant excluded due to self-reported physiological symptoms unrelated to the study intervention. One participant excluded due to physical difficulty unrelated to the study intervention
This is a measurement of endurance and functional ability that assesses the participants ability to walk a distance over a time period of 6 minutes. It is measured in distance with greater distances indicating improved levels of endurance and functional ability.
Outcome measures
| Measure |
Hip Exoskeleton for Stroke Gait Assistance
n=10 Participants
This study will be conducted on a sample population of stroke subjects (single arm). Subjects will be tested with the hip exoskeleton and baseline.
|
|---|---|
|
6 Minute Walk Test
Baseline
|
258.45 Meters
Standard Deviation 72.92
|
|
6 Minute Walk Test
Hip Exoskeleton
|
282.7 Meters
Standard Deviation 66.65
|
SECONDARY outcome
Timeframe: 5 daysPopulation: One participant excluded due to self-reported physiological symptoms unrelated to the study intervention.
The Modified Stroke Impact Scale (SIS) is a self-report questionnaire that evaluates disability and health-related quality of life after stroke. Each item is rated in a 5-point Likert scale in terms of the difficulty the patient has experienced in completing each item. Scores are transformed to a 0-100 scale, with 0 indicating the poorest perceived health status and 100 indicating the best, across domains of disability and health-related quality of life. Higher scores are indicative of improved quality of life.
Outcome measures
| Measure |
Hip Exoskeleton for Stroke Gait Assistance
n=11 Participants
This study will be conducted on a sample population of stroke subjects (single arm). Subjects will be tested with the hip exoskeleton and baseline.
|
|---|---|
|
Modified Stroke Impact Scale
Baseline
|
65.8 Units on a scale
Standard Deviation 13.9
|
|
Modified Stroke Impact Scale
Hip Exoskeleton
|
82.29 Units on a scale
Standard Deviation 13.52
|
SECONDARY outcome
Timeframe: 5 daysPopulation: One participant excluded due to self-reported physiological symptoms unrelated to the study intervention.
The modified activities specific balance confidence is a self-report measure of balance confidence in performing various activities without losing balance or experiencing a sense of unsteadiness. Confidence is rated for various activities on a scale from 0% to 100% for each activity, with 0% indicative of no confidence and 100% indicative of complete confidence. Scores reflect balance confidence with higher scores indicative of improved balance confidence.
Outcome measures
| Measure |
Hip Exoskeleton for Stroke Gait Assistance
n=11 Participants
This study will be conducted on a sample population of stroke subjects (single arm). Subjects will be tested with the hip exoskeleton and baseline.
|
|---|---|
|
Modified Activities-specific Balance Confidence
Hip Exoskeleton
|
73.66 Units on a scale
Standard Deviation 24.74
|
|
Modified Activities-specific Balance Confidence
Baseline
|
58.76 Units on a scale
Standard Deviation 19.69
|
SECONDARY outcome
Timeframe: 5 daysPopulation: One participant excluded due to self-reported physiological symptoms unrelated to the study intervention.
This will be measured as the participant walks on a treadmill at their fastest and safest walking speed. This measure will be recorded in meters/seconds with higher values indicating faster speed and lower values indicating slower speeds.
Outcome measures
| Measure |
Hip Exoskeleton for Stroke Gait Assistance
n=11 Participants
This study will be conducted on a sample population of stroke subjects (single arm). Subjects will be tested with the hip exoskeleton and baseline.
|
|---|---|
|
Fast Self-selected Walking Speed
Hip Exoskeleton
|
1.01 Meters per Second
Standard Deviation 0.25
|
|
Fast Self-selected Walking Speed
Baseline
|
0.95 Meters per Second
Standard Deviation 0.2
|
Adverse Events
Hip Exoskeleton for Stroke Gait Assistance - Baseline Intervention
Hip Exoskeleton for Stroke Gait Assistance - Hip Exoskeleton Intervention
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place